Synapsoft logo
AI Insights from Disclosures
Searching...
Cytogen, Inc. 217330
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Cytogen, Inc. is developing both a platform business providing biological services, such as support for pharmaceutical companies' anticancer drug development processes, based on its CTC-based Liquid Biopsy platform, and diagnostic-based services and products using CTC-based Liquid Biopsy. In its Liquid Biopsy platform business, the company's basic approach is to analyze CTCs in blood samples collected from clinical patients during pharmaceutical companies' anticancer drug development processes and provide the resulting data to those pharmaceutical companies.
Representative Director Ahn Jihun
Founded March 18, 2010
Corporation Type KOSDAQ
Industry Classification Research and experimental development on medical sciences and pharmacy
Corporate number 13111-0251395
Business number 129-86-44021
Phone Number 02-6925-1070
Fax Number 02-6925-1071
Website cytogenlab.com
Company Address 60 Gwacheon-daero 7na-gil, Gwacheon-si, Gyeonggi-do
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant